Application of Targeted Therapies and Response Heterogeneity in Two Children With T‐Cell Acute Lymphoblastic Leukemia With BCL11B::TLX3 Fusion Genes
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignancy that predominantly affects adolescents and young adults, accounting for approximately 15% of all childhood leukemias [ 1, 2 ]. It is characterized by the malignant transformation of T-cell precursors leading to aberrant proliferation. T...